Transduction of murine bone marrow cells with an MDR1 vector enables ex vivo stem cell expansion, but these expanded grafts cause a myeloproliferative syndrome in transplanted mice

Blood

Volumn 92, Issue 7, 1998, Pages 2269-2279

  Bunting, Kevin D ^b   Galipeau, Jacques ^b   Topham, David ^b   Benaim, Ely ^b   Sorrentino, Brian P ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; INTERLEUKIN 3; INTERLEUKIN 6; STEM CELL FACTOR;

ANIMAL CELL; ARTICLE; BONE MARROW CELL; CELL LINE; CELL PROLIFERATION; CONTROLLED STUDY; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; KINETICS; LEUKOCYTE COUNT; MOUSE; MULTIDRUG RESISTANCE; MYELOPROLIFERATIVE DISORDER; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

EID: 0032188998     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v92.7.2269     Document Type: Article

References (50)

1. Bodine DM, Karlsson S, Nienhuis AW: Combination of interleukins 3 and 6 preserves stem cell function in culture and enhances retro virus-mediated gene transfer into hematopoietic stem cells. Proc Natl Acad Sci USA 86:8897, 1989
2. Luskey BD, Rosenblatt M, Zsebo K, Williams DA: Stem cell factor, interleukin-3, and interleukin-6 promote retroviral-mediated gene transfer into murine hematopoietic stem cells. Blood 80:396, 1992
3. Kittler EL, Peters SO, Crittenden RB, Debatis ME, Ramshaw HS, Stewart FM, Quesenberry PJ: Cytokine-facilitated transduction leads to low-level engraftment in nonablated hosts. Blood 90:865, 1997
4. Traycoff CM, Coraetta K, Yoder MC, Davidson A, Srour EF: Ex vivo expansion of murine hematopoietic progenitor cells generates classes of expanded cells possessing different levels of bone marrow repopulating potential. Exp Hcmatol 24:299, 1996
5. Peters SO, Kittler EL, Ramshaw HS, Quesenberry PJ: Murine marrow cells expanded in culture with IL-3, IL-6, IL-11, and SCF acquire an engraftment defect in normal hosts. Exp Hematol 23:461, 1995
6. Miller CL, Eaves CJ: Expansion in vitro of adult murine hematopoietic stem cells with transplantable lympho-myeloid reconstituting ability. Proc Natl Acad Sci USA 94:13648, 1997
7. Muench MO, Firpo MT, Moore MA: Bone marrow transplantation with interleukin-1 plus kit-ligand ex vivo expanded bone marrow accelerates hematopoietic reconstitution in mice without the loss of stem cell lineage and proliferative potential. Blood 81:3463, 1993
8. Bodine DM, Orlic D, Birkett NC, Seidel NE, Zsebo KM: Stem cell factor increases colony-forming unit-spleen number in vitro in synergy with interleukin-6, and in vivo in Sl/Sld mice as a single factor. Blood 79:913, 1992
9. + peripheral blood progenitor cells after introduction of a mutated dihydrofolate reductase cDNA via retroviral gene transfer. Blood 85:566, 1995
10. Petzer AL, Hogge DE. Landsdorp PM, Reid DS, Eaves CJ: Self-renewal of primitive human hematopoietic cells (long-term-culture-initiating cells) in vitro and their expansion in defined medium. Proc Natl Acad Sci USA 93:1470, 1996
11. Petzer AL, Zandstra PW, Piret JM, Eaves CJ: Differential cytokine effects on primitive (CD34+CD38-) human hematopoietic cells: Novel responses to Flt3-ligand and thrombopoietin, J Exp Med 183:2551, 1996
12. Zandstra PW, Conneally E, Petzer AL, Piret JM, Eaves CJ: Cytokine manipulation of primitive human hematopoietic cell selfrenewal. Proc Natl Acad Sci USA 94:4698, 1997
13. Bhatia M, Wang JY, Kapp U, Bonnet D, Dick JE: Purification of primitive human hematopoietic cells capable of repopulating immunedeficient mice. Proc Natl Acad Sci USA 94:5320, 1997
14. Gan OI, Murdoch B, Larochelle A, Dick JE: Differential maintenance of primitive human SCID-repopulating cells, clonogenic progenitors, and long-term culture-initiating cells after incubation on human bone marrow stromal cells. Blood 90:641, 1997
15. Larochelle A, Vormoor J, Hanenberg H, Wang JC, Bhatia M, Lapidot T, Moritz T, Murdoch B, Xiao XL, Kato I, Williams DA, Dick JE: Identification of primitive human hematopoietic cells capable of repopulating NOD/SCID mouse bone marrow: Implications for gene therapy. Nat Med 2:1329, 1996
16. Bhatia M, Bonnet D, Kapp U, Wang JC, Murdoch B, Dick JE: Quantitative analysis reveals expansion of human hematopoietic repopulating cells after short-term ex vivo culture. J Exp Med 186:619, 1997
17. Galipeau J, Benaim E, Spencer HT, Blakley RL, Sorrentino, BP: A bicistronic retroviral vector for protecting hematopoietic cells against antifolates and P-glycoprotein effluxed drugs. Hum Gene Ther 8:1773, 1997
18. Spencer HT, Sleep SE, Rehg JE, Blakley RL, Sorrentino BP: A gene transfer strategy for making bone marrow cells resistant to trimetrexate. Blood 87:2579, 1996
19. Safa AR, Stern RK, Choi K, Agresti M, Tamai I, Mehta, ND, Roninson IB: Molecular basis of preferential resistance to colchicine in multidrug-resistant human cells conferred by Gly-185-Val-185 substitution in P-glycoprotein. Proc Natl Acad Sci USA 87:7225, 1990
20. Sorrentino BP, McDonagh KT, Woods D, Orlic D: Expression of retroviral vectors containing the human multidrug resistance 1 cDNA in hematopoietic cells of transplanted mice. Blood 86:491, 1995
21. Scarpa M, Cournoyer D, Muzny DM, Moore KA, Belmont JW, Caskey CT: Characterization of recombinant helper retroviruses from Moloney-based vectors in ecotropic and amphotropic packaging cell lines. Virology 180:849, 1991
22. Sorrentino BP, Brandt SJ, Bodine D, Gottesman M, Pastan I, Cline A. Nienhuis AW: Selection of drug-resistant bone marrow cells in vivo after retroviral transfer of human MDR1. Science 257:99, 1992
23. Donahue RE, Kessler SW, Bodine D, McDonagh K, Dunbar C, Goodman S, Agricola B, Byrne E, Raffeid M, Moen R: Helper virus induced T cell lymphoma in nonhuman primates after retroviral mediated gene transfer. J Exp Med 176:1125, 1992
24. Vanin EF, Kaloss M, Broscius C, Nienhuis AW: Characterization of replication-competent retroviruses from nonhuman primates with virus-induced T-cell lymphomas and observations regarding the mechanism of oncogenesis. J Virol 68:4241, 1994
25. Lander MR, Chattopadhyay SK: A Mus dunni cell line that lacks sequences closely related to endogenous murine leukemia viruses and can be infected by ecotropic, amphotropic, xenotropic, and mink cell focus-forming viruses. J Virol 52:695, 1984
26. Hanania EG, Deisseroth AB: Serial transplantation shows that early hematopoietic precursor cells are transduced by MDR-1 retroviral vector in a mouse gene therapy model. Cancer Gene Ther 1:21, 1994
27. Peters SO, Kittler EL, Ramshaw HS, Quesenberry PJ: Ex vivo expansion of murine marrow cells with interleukin-3 (IL-3), IL-6. IL-11, and stem cell factor leads to impaired engraftment in irradiated hosts. Blood 87:30, 1996
28. Williams DA: Ex vivo expansion of hematopoietic stem and progenitor cells-Robbing Peter to pay Paul? Blood 81:3169, 1993
29. Traycoff CM, Orazi A, Ladd AC, Rice S, McMahel J, Srour EF: Proliferation-induced decline of primitive hematopoietic progenitor cell activity is coupled with an increase in apoptosis of ex vivo expanded CD34+ cells. Exp Hematol 26:53, 1998
30. Bezombes C, Maestre N, Laurent G, Levade T, Bettaieb A, Jaffrezou JP: Restoration of TNF-alpha-induced ceramide generation and apoptosis in resistant human leukemia KG la cells by the Pglycoprotein blocker PSC833. FASEB J 12:101, 1998
31. Robinson LJ. Roberts WK, Ling TT, Lamming D, Sternberg SS, Roepe PD: Human MDR 1 protein overexpression delays the apoptotic cascade in Chinese hamster ovary fibroblasts. Biochemistry 36:11169, 1997
32. Gruol DJ, Bourgeois S: Expression of the mdrl P-glycoprotein gene: A mechanism of escape from glucocorticoid-induced apoptosis. Biochem Cell Biol 72:561, 1994
33. van Helvoort A, Smith AJ, Sprong H, Fritzsche I, Schinkel AH, Borst P, van Meer G: MDR 1 P-glycoprotein is a lipid translocase of broad specificity, while MDR3 P-glycoprotein specifically translocates phosphatidylcholine. Cell 87:507, 1996
34. Martin SJ. Finucane DM, Amarante-Mendes GP. O'Brien GA, Green DR: Phosphatidylserine externalization during CD95-induced apoptosis of cells and cytoplasts requires ICE/CED-3 protease activity. J Biol Chem 271:28753, 1996
35. Gros P, Dhir R, Croop J, Talbot F: A single amino acid substitution strongly modulates the activity and substrate specificity of the mouse mdrl and mdr3 drug efflux pumps. Proc Natl Acad Sci USA 88:7289, 1991
36. Chaudhary PM. Roninson IB: Expression and activity of Pglycoprotein, a multidrug efflux pump, in human hematopoietic stem cells. Cell 66:85, 1991
37. Fleming WH, Alpern EJ, Uchida N, Ikuta K, Spangrude GJ, Weissman IL: Functional heterogeneity is associated with the cell cycle status of murine hematopoietic stem cells. J Cell Biol 122:897, 1993
38. Goodell MA, Brose K, Paradis G, Conner AS, Mulligan RC: Isolation and functional properties of murine hematopoietic stem cells that are replicating in vivo. J Exp Med 183:1797, 1996
39. Uchida N, Combs J, Chen S, Zanjani E, Huffman R, Tsukamoto A: Primitive human hematopoietic cells displaying differential efflux of the rhodamine 123 dye have distinct biological activities. Blood 88:1297, 1996
40. Udomsakdi C, Eaves CJ, Sutherland HJ, Lansdorp PM: Separation of functionally distinct subpopulations of primitive human hematopoietic cells using rhodamine-123. Exp Hematol 19:338, 1991
41. Russo D, Marie JP, Zhou DC, Faussat AM, Delmer A, Maisonneuve L, Ngoc, LH, Baccarani M, Zittoun R: Coexpression of anionic glutathione-S-transferase (GST pi) and multidrug resistance (mdrl) genes in acute myeloidand lymphoid leukemias. Leukemia 8:881, 1994
42. Gekeler V, Frese G, Noller A, Handgretinger R, Wilisch A, Schmidt H, Muller CP, Dopfer R, Klingebiel T, Diddens H: Mdrl/Pglycoprotein, topoisomerase, and glutathione-S-transferase pi gene expression in primary and relapsed state adult and childhood leukaemias. Br J Cancer 66:507, 1992
43. Pirker R, Wallner J, Geissler K, Linkesch W, Haas OA, Bettelheim P, Hopfner M, Scherrer R, Valent P, Havelec L: MDR1 gene expression and treatment outcome in acute myeloid leukemia. J Natl Cancer Inst 83:708, 1991
44. Schinkel AH, Smit JJ, van Tellingen O, Beijnen JH, Wagenaar E, van Deemter L, Mol CA, van der Valk MA, Robanus-Maandag EC, te RH: Disruption of the mouse mdrla P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs. Cell 77:491, 1994
45. Smit JJ, Schinkel AH, Oude ER, Groen AK, Wagenaar E, van Deemter L, Mol CA, Ottenhoff R, van der Lugt NM, van, Roon MA: Homozygous disruption of the murine mdr2 P-glycoprotein gene leads to a complete absence of phospholipid from bile and to liver disease. Cell 75:451, 1993
46. Schinkel AH, Mayer U, Wagenaar E, Mol ÇA, van Deemter L, Smit JJ, van der VM. Voordouw AC, Spits H, van Tellingen O, Zijlmans JM, Fibbe, WE, Borst P: Normal viability and altered pharmacokinetics in mice lacking mdrl-type (dru g-transporting) Pglycoproteins. Proc Natl Acad Sci USA 94:4028, 1997
47. Podda S, Ward M, Himelstein A, Richardson C, de la Flor-Weiss E, Smith L, Gottesman M, Pastan I, Bank A: Transfer and expression of the human multiple drug resistance gene into live mice. Proc Natl Acad Sci USA 89:9676, 1992
48. Hesdortfer C, Ayello J, Ward M, Kaubisch A, Vahdat L, Balmaceda C, Garrett TD, Fetell M, Reiss R, Bank A, Antman K: Phase I trial of retroviral mediated transfer of the human MDRI gene as marrow chemoprotection in patients undergoing high-dose chemotherapy and autologous stem-cell transplantation. J Clin Oncol 16:165, 1998
49. Hanania EG, Giles RE, Kavanagh J, Fu SQ, Ellerson D, Zu Z, Wang T, Su Y, Kudelka A, Rahman Z, Holmes F, Hortobagyi G, Claxton D, Bachier C, Thall P, Cheng S, Hester J, Ostrove JM, Bird RE, Chang A, Korbling M, Seong D, Cote R, Holzmayer T, Deisseroth AB, Mechetner E: Results of MDR-1 vector modification trial indicate that granulocyte/macrophage colony-forming unit cells do not contribute to posttransplant hematopoietic recovery following intensive systemic therapy. Proc Natl Acad Sci USA 93:15346, 1996
50. Howk RS, Troxler DH, Lowy D, Duesberg PH, Scolnick EM: Identification of a 30S RNA with properties of a defective type C virus in murine cells. J Virol 25:115, 1978